Option chain shows key data for AlTi Global's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for AlTi Global.

AlTi Global (NASDAQ:ALTI) Stock, Option Chain

AlTi Global

Alvarium Tiedemann Hldgs

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments that includes Wealth Management and Strategic Alternatives. Wealth Management includes providing holistic solutions for their wealth management clients through their comprehensive range of wealth management services, including investment management and advisory services. Strategic Alternatives segment, it assists their investors with alternative investments and co-investments by providing access to highly differentiated opportunities in these areas.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ALPN

ALTI

ANAB

ELVN

FVRR

GYRE

JANX

NEXN

NRIX

RLYB

STEP

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday.

Shares of  Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session.

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday

Pre-Market Outlook

BNAI

CJET

CLOV

FOUR

GERN

HGAS

IDAI

JOAN

LIDR

LOGI

NBTX

NVEI

RILY

TSVT

VJET

Shares of  Nuvei Corp (NASDAQ: NVEI) rose sharply in today’s pre-market trading following a report indicating the company is in buyout talks with Advent International.

Nuvei shares jumped 14.1% to $24.82 in pre-market trading

Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

SBSW

U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining by around 100 points on Monday.

Shares of  Logitech International S.A. (NASDAQ: LOGI) fell in today’s pre-market trading.

Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

AlTi Global Inc

ALTIGEN COMMUNS INC by Altigen Communications, Inc.

AltiGen Communications Inc

Altice USA Inc

Altima Energy Inc

Altimar Acquisition Corp III Warrants (08/03/2026)

Altimmune Inc

ALTIPLANO METALS INC ORD by Altiplano Metals Inc.

Altiplano Metals Inc

ALTISOURCE ASSET MGMT by Altisource Asset Management Corp

Altisource Asset Management Corp

Altisource Asset Management Corp Com

Altisource Portfolio Solutions S.A. - Common Stock

Altisource Portfolio Solutions SA

Altitude Acquisition Corp Units (1 Ord Share Class A & 1/2 War)

Altitude Acquisition Corp

Altitude Acquisition Corp Warrants (30/11/2027)

Altitude Acquisition Corp Ordinary Shares - Class A

ALTITUDE INTL INC by Altitude International Holdings, Inc.

Altitude International Holdings Inc

Altium Ltd

ALTIUS MINERALS CORP by Altius Minerals Corp.

Altius Minerals Corp

Altius Renewable Royalties Corp Ordinary Shares

AlTi Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) reported quarterly losses of $(0.88) per share. This is a 37.59 percent increase over losses of $(1.41) per share from the same period last year. The company reported quarterly sales of $53.34 million which missed the analyst consensus estimate of $55.60 million by 4.06 percent. This is a 10.70 percent increase over sales of $48.19 million the same period last year.

Earnings

Earnings Misses

AlTi Global Q3 EPS $(0.88) Up From $(1.41) YoY, Sales $53.34M Miss $55.60M Estimate

AlTi Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) will release its quarterly earnings report on Friday, 2024-11-08. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate AlTi Global to report an earnings per share (EPS) of $0.01.
Investors in AlTi Global are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company missed EPS by $0.01, leading to a 0.0% drop in the share price the following trading session.
Here's a look at AlTi Global's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.06</td>
<td>0.03</td>
<td></td>
<td>0.05</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.07</td>
<td>0.18</td>
<td>-0.06</td>
<td>-0.13</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>-2.0%</td>
<td>-1.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>

<h3>Market Performance of AlTi Global's Stock</h3>
Shares of AlTi Global were trading at $4.93 as of November 06. Over the last 52-week period, shares are down 39.43%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/ALTI/earnings">To track all earnings releases for AlTi Global visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights Ahead: AlTi Global's Quarterly Earnings

AlTi Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) is set to give its latest quarterly earnings report on Friday, 2024-11-08. Here's what investors need to know before the announcement.
Analysts estimate that AlTi Global will report an earnings per share (EPS) of $0.01. 
Anticipation surrounds AlTi Global's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS missed by $0.01, leading to a 0.0% drop in the share price on the subsequent day.
Here's a look at AlTi Global's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.06</td>
<td>0.03</td>
<td></td>
<td>0.05</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.07</td>
<td>0.18</td>
<td>-0.06</td>
<td>-0.13</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>-2.0%</td>
<td>-1.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>

<h3>Performance of AlTi Global Shares</h3>
Shares of AlTi Global were trading at $4.93 as of November 06. Over the last 52-week period, shares are down 39.35%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/ALTI/earnings">To track all earnings releases for AlTi Global visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For AlTi Global

Allianz X today announced a joint venture ("JV") with AlTi Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) ("AlTi" or the "Company"), a leading independent global wealth manager with over $72 billion in combined assets, enabling it to form a strategic partnership with Allianz Global Investors ("AllianzGI"), one of the world's leading active investment managers and a wholly owned subsidiary of Allianz SE (XETRA: ALV), to create a leading private markets offering for the UHNW wealth segment.
Through the joint venture, AlTi and AllianzGI will launch a private markets investment program for UHNW clients that will benefit from AllianzGI's exceptional network and scale. By investing alongside Allianz, the program will provide unprecedented access to leading third-party managers with outstanding track records, significant scale benefits, low minimum ticket sizes, and expanded investment opportunities, including secondaries and co-investments.
The program will initially focus on the approximately $1.5 trillion global private debt market1, leveraging AllianzGI's long-standing and strong track record in private markets for over 25 years, and unique position in this dynamic and growing asset class. The wider Allianz Group, including AllianzGI, is one of the largest private debt investors worldwide.

Allianz X and AlTi Team Up to Offer Exclusive Private Markets Access for Ultra-Wealthy

WIIM

CNFR

CRBG

HOOD

IBKR

NTRS

UPST

WENA

Shares of companies within the broader financial sector are trading lower amid overall market weakness as investors react to jobs data.

ALLY

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FFBC

FRGE

FTFT

GOCO

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HIPO

MEGL

SLQT

TCJH

TREE

Shares of companies within the broader financial sector are trading higher amid overall market strength following Fed Chair Powell's comments about the economy and future rate cuts.

General

AITi Global shares are trading higher. The company reported Q2 financial results.

AlTi Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent.&nbsp;

AlTi Global Q2 2024 Adj EPS $(0.07) Misses $(0.06) Estimate

AlTi Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) reported quarterly sales of $49.45 million which missed the analyst consensus estimate of $51.80 million by 4.53 percent. This is a 4.68 percent decrease over sales of $51.88 million the same period last year.

AlTi Global Q2 Sales $49.45M Miss $51.80M Estimate

AlTi Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.03 by 500 percent. This is a 115.13 percent increase over losses of $(1.19) per share from the same period last year. The company reported quarterly sales of $50.81 million which missed the analyst consensus estimate of $61.50 million by 17.38 percent. This is a 12.46 percent decrease over sales of $58.05 million the same period last year.

AlTi Global Q1 EPS $0.18 Beats $0.03 Estimate, Sales $50.81M Miss $61.50M Estimate

AlTi continues to execute strategy to expand scale and reach of its global ultra-high-net-worth ("UHNW") wealth management business in existing and new markets.
AlTi Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) ("AlTi" or the "Company"), a leading independent global wealth manager with over $70 billion in combined assets, announces the acquisition of Envoi, LLC ("Envoi"), a leading family office focused on multi-generational family wealth with assets under management (AUM) of approximately $3.0 billion.
This follows AlTi's recent acquisition of US-based independent advisory firm East End Advisors, as AlTi accelerates its strategy to become the leading global independent wealth management platform for the UHNW segment, with targeted expertise in alternatives.
In line with this strategic goal, AlTi is using funding of up to $450 million from Allianz X and Constellation Wealth Capital to fund its mergers and acquisitions pipeline and organic growth activities.

AlTi Tiedemann Global Announces Acquisition Of Midwest Family Office, Envoi; Financial Terms Not Disclosed

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday.
Shares of Enliven Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elvn#NASDAQ">ELVN</a>) rose sharply during Thursday&rsquo;s session.
Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in <a href="https://www.benzinga.com/general/biotech/24/04/38199756/enliven-therapeutics-announces-proof-of-concept-data-from-phase-1-clinical-trial-of-elvn-001-in-c">chronic myeloid leukemia</a>.
Enliven Therapeutics shares surged 26% to $24.97 on Thursday.
Here are some other big stocks recording losses in today&rsquo;s session.
<ul>
<li>Rallybio Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rlyb#NASDAQ">RLYB</a>) shares gained 89.6% to $3.09 after the company announced a collaboration with Johnson &amp; Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.</li>
<li>Alpine Immune Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alpn#NASDAQ">ALPN</a>) jumped 36.6% to $64.25 after Vertex entered into an agreement to acquire the company.</li>
<li>Janux Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/janx#NASDAQ">JANX</a>) shares jumped 16.8% to $52.15 following Wednesday reports suggesting the company is said to weigh a possible sale.</li>
<li>Gyre Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gyre#NASDAQ">GYRE</a>) rose 14.6% to $15.91.</li>
<li>AnaptysBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anab#NASDAQ">ANAB</a>) rose 11.4% to $24.72. Wells Fargo analyst Derek Archila initiated coverage on AnaptysBio with an Overweight rating and announced a price target of $56.</li>
<li>Fiverr International Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fvrr#NYSE">FVRR</a>) gained 10.5% to $21.25 after the company&#39;s board authorized a $100 million share repurchase program.</li>
<li>GigaCloud Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gct#NASDAQ">GCT</a>) shares jumped 10.2% to $34.18.</li>
<li>Nurix Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrix#NASDAQ">NRIX</a>) climbed 9.6% to $17.21. Baird analyst Joel Beatty maintained Nurix Therapeutics with an Outperform and raised the price target from $24 to $25.</li>
<li>AlTi Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alti#NASDAQ">ALTI</a>) gained 9.3% to $5.06.</li>
<li>Nexxen International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexn#NASDAQ">NEXN</a>) rose 7.3% to $5.62.</li>
<li>StepStone Group LP (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/step#NASDAQ">STEP</a>) gained 7.1% to $37.46 after JP Morgan upgraded the stock from Neutral to Overweight.</li>
<li>Frontline plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fro#NYSE">FRO</a>) rose 5.9% to $24.47.</li>
<li>IAMGOLD Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iag#NYSE">IAG</a>) gained 3.6% to $3.74.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/04/38200324/dell-designer-brands-and-2-other-stocks-insiders-are-selling"> Dell, Designer Brands And 2 Other Stocks Insiders Are Selling</a>

AlTi Tiedemann Global Acquires East End Advisors For Initial Purchase Price Of $76M; Transaction Expected To Close Early In The Second Quarter

Management

AlTi Tiedemann Promotes Kevin Moran To President

Shares of Nuvei Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvei#NASDAQ">NVEI</a>) rose sharply in today&rsquo;s pre-market trading following a report indicating the company is in buyout talks with Advent International.
Nuvei shares jumped 14.1% to $24.82 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Solidion Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sti#NASDAQ">STI</a>) shares gained 62.1% to $2.82 in pre-market trading after surging around 34% on Friday. The company, last week, announced the pricing of a $3.85 million private placement.</li>
<li>JOANN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/joan#NASDAQ">JOAN</a>) shares rose 42.6% to $0.3285 in pre-market trading. JOANN entered into an agreement to reduce debt and receive $132 million in new capital and related financial accommodations.</li>
<li>Brand Engagement Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnai#NASDAQ">BNAI</a>) rose 47.7% to $15.60 in pre-market trading after jumping 40% on Friday.</li>
<li>2seventy bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsvt#NASDAQ">TSVT</a>) climbed 31% to $5.24 in pre-market trading. The FDA Advisory Committee voted in favor of Bristol Myers Squibb&#39;s and 2seventy Bio&#39;s Abecma for triple-class exposed multiple myeloma in earlier lines of therapy.</li>
<li>voxeljet AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vjet#NASDAQ">VJET</a>) gained 27.9% to $0.5999 in pre-market trading. The company recently announced it will voluntarily delist its ADSs from Nasdaq and deregister its ADSs. The company also announced the restatement and extension of its loan financing with Anzu.</li>
<li>Global Gas Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hgas#NASDAQ">HGAS</a>) shares rose 21.8% to $1.90 in pre-market trading after falling 25% on Friday.</li>
<li>AEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lidr#NASDAQ">LIDR</a>) gained 21.6% to $1.40 in pre-market trading. AEye is expected to release its financial results for the fourth quarter after the closing bell on March 26, 2024.</li>
<li>Aurora Cannabis Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acb#NASDAQ">ACB</a>) rose 15.4% to $3.67 in pre-market trading after surging 10% on Friday.</li>
<li>T Stamp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idai#NASDAQ">IDAI</a>) shares gained 13.2% to $1.21 in pre-market trading.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) dipped 15.3% to $1.8601 in pre-market trading after jumping 38% on Friday.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) fell 11% to $15.65 pre-market trading. B. Riley Financial failed to file its audited results after the end of extension period.</li>
<li>Nanobiotix S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbtx#NASDAQ">NBTX</a>) fell 10.8% to $6.19 in pre-market trading after gaining 10% on Friday.</li>
<li>Clover Health Investments, Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clov#NASDAQ">CLOV</a>) fell 9.7% to $0.72 in pre-market trading after surging 10% on Friday.</li>
<li>Shift4 Payments, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/four#NASDAQ">FOUR</a>) fell 9.1% to $70.50 pre-market trading. The company&rsquo;s CEO Jared Isaacman said bids from potential contenders failed to sufficiently value the firm, according to Bloomberg News.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) declined 5.8% to $35.57 in pre-market trading after gaining around 3% on Friday.</li>
<li>AlTi Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alti#NASDAQ">ALTI</a>) shares tumbled 6.7% to $5.90 in pre-market trading. AlTi Global posted a loss of 87 cents per share for the fourth quarter, versus a year-ago loss of 21 cents per share. The company&rsquo;s quarterly sales came in at $91.71 million.</li>
<li>Geron Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gern#NASDAQ">GERN</a>) shares fell 5.1% to $3.19 in pre-market trading after jumping 92% on Friday. The company announced that the FDA Oncologic Drugs Advisory Committee voted in favor of the clinical benefit/risk profile of imetelstat for the treatment of transfusion-dependent anemia in adult patients with low-to-intermediate-1 risk myelodysplastic syndromes.</li>
<li>Logitech International S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/logi#NASDAQ">LOGI</a>) shares fell 4.8% to $90.14 in pre-market trading. Logitech announced the departure of CFO Chuck Boynton and reaffirmed its 2024 financial outlook.</li>
<li>Chijet Motor Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cjet#NASDAQ">CJET</a>) shares tumbled 12.2% to $0.43 after gaining 52% on Friday.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37770294/saic-stoneco-and-3-stocks-to-watch-heading-into-monday"> SAIC, StoneCo And 3 Stocks To Watch Heading Into Monday</a>

U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining by around 100 points on Monday.
Shares of Logitech International S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/logi#NASDAQ">LOGI</a>) fell in <a href="https://www.benzinga.com/quote/LOGI/news">today&rsquo;s pre-market trading.</a>
Logitech announced the departure of CFO Chuck Boynton and reaffirmed its 2024 financial outlook.
Logitech International shares declined 4.8% to $90.14in pre-market trading.
Here are some big stocks recording losses in today&rsquo;s pre-market trading session.
<ul>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) shares dipped 11% to $15.65 pre-market trading. B. Riley Financial failed to file its audited results after the end of extension period.</li>
<li>Nanobiotix S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbtx#NASDAQ">NBTX</a>) shares tumbled 10.8% to $6.19 in pre-market trading after gaining 10% on Friday.</li>
<li>Shift4 Payments, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/four#NASDAQ">FOUR</a>) dipped 9.1% to $70.50 pre-market trading. The company&rsquo;s CEO Jared Isaacman said bids from potential contenders failed to sufficiently value the firm, according to Bloomberg News.</li>
<li>AlTi Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alti#NASDAQ">ALTI</a>) shares fell 6.7% to $5.90 in pre-market trading. AlTi Global posted a loss of 87 cents per share for the fourth quarter, versus a year-ago loss of 21 cents per share. The company&rsquo;s quarterly sales came in at $91.71 million.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) fell 5.8% to $35.57 in pre-market trading after gaining around 3% on Friday.</li>
<li>Geron Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gern#NASDAQ">GERN</a>) shares declined 5.1% to $3.19 in pre-market trading after jumping 92% on Friday. The company announced that the FDA Oncologic Drugs Advisory Committee voted in favor of the clinical benefit/risk profile of imetelstat for the treatment of transfusion-dependent anemia in adult patients with low-to-intermediate-1 risk myelodysplastic syndromes.</li>
<li>Sibanye Stillwater Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbsw#NYSE">SBSW</a>) shares fell 3.8% to $4.35 in pre-market trading.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37770309/investor-sentiment-falls-further-s-p-500-records-second-weekly-loss"> Investor Sentiment Falls Further, S&amp;P 500 Records Second Weekly Loss</a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects Science Applications International Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/saic#NASDAQ">SAIC</a>) to report quarterly earnings at $1.43 per share on revenue of $1.64 billion before the opening bell, according to data from Benzinga Pro. SAIC shares rose 0.6% to $143.48 in after-hours trading.
Analysts are expecting Comtech Telecommunications Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmtl#NASDAQ">CMTL</a>) to have earned 22 cents per share on revenue of $152.85 million for the latest quarter. The company will release earnings after the markets close. Comtech Telecommunications shares rose 3.9% to $4.77 in after-hours trading.
AlTi Global (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alti#NASDAQ">ALTI</a>) posted a loss of 87 cents per share for the fourth quarter, versus a year-ago loss of 21 cents per share. The company&rsquo;s quarterly sales came in at $91.71 million. AlTi Global shares fell 6.7% to $5.90 in the after-hours trading session.
Check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
After the markets close, StoneCo Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stne#NASDAQ">STNE</a>) is projected to post quarterly earnings at 30 cents per share on revenue of $685.73 million. StoneCo shares fell 0.3% to close at $17.30 on Friday.
Analysts expect JOYY Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yy#NASDAQ">YY</a>) to post quarterly earnings at 77 cents per share on revenue of $558.30 million after the closing bell. JOYY shares gained 1.3% to $32.68 in the after-hours trading session.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37744364/insiders-buying-united-fire-group-and-3-other-stocks"> Insiders Buying United Fire Group And 3 Other Stocks </a>

CMTL

SAIC

STNE

SAIC, StoneCo And 3 Stocks To Watch Heading Into Monday

AlTi Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) reported quarterly losses of $(0.87) per share. This is a 314.29 percent decrease over losses of $(0.21) per share from the same period last year. The company reported $91.71 million in sales this quarter.

AlTi Global Q4 EPS $(0.87) Down From $(0.21) YoY, Sales $91.71M

<h3>Companies Reporting Before The Bell</h3>
&bull; EHang Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EH#NASDAQ">EH</a>) is expected to report quarterly loss at $0.10 per share on revenue of $7.83 million.
&bull; NeoGenomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) is likely to report quarterly earnings at $0.17 per share on revenue of $182.13 million.
&bull; Prestige Consumer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBH#NYSE">PBH</a>) is estimated to report quarterly earnings at $1.20 per share on revenue of $1.61 billion.
&bull; Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) is projected to report quarterly earnings at $2.55 per share on revenue of $477.49 million.
&bull; RLX Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLX#NYSE">RLX</a>) is expected to report quarterly earnings at $0.02 per share on revenue of $66.52 million.
&bull; KVH Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KVHI#NASDAQ">KVHI</a>) is expected to report quarterly loss at $0.03 per share on revenue of $32.32 million.
&bull; Oxford Square Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXSQ#NASDAQ">OXSQ</a>) is estimated to report earnings for its fourth quarter.
&bull; Desktop Metal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DM#NYSE">DM</a>) is projected to report quarterly loss at $0.05 per share on revenue of $50.83 million.
&bull; Paltalk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALT#NASDAQ">PALT</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $3.53 million.
&bull; GigaCloud Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>) is likely to report quarterly earnings at $0.58 per share on revenue of $224.15 million.
&bull; Jabil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) is estimated to report quarterly earnings at $1.66 per share on revenue of $6.89 billion.
&bull; Buckle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKE#NYSE">BKE</a>) is expected to report quarterly earnings at $1.44 per share on revenue of $383.63 million.
&bull; Summit Midstream Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMLP#NYSE">SMLP</a>) is projected to report earnings for its fourth quarter.
&bull; CBAK Energy Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBAT#NASDAQ">CBAT</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $58.86 million.
&bull; ProPhase Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) is likely to report quarterly loss at $0.26 per share on revenue of $10.69 million.
&bull; Tredegar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TG#NYSE">TG</a>) is estimated to report earnings for its fourth quarter.
&bull; Soho House (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHCO#NYSE">SHCO</a>) is expected to report quarterly loss at $0.07 per share on revenue of $304.52 million.
&bull; Telos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLS#NASDAQ">TLS</a>) is likely to report quarterly loss at $0.12 per share on revenue of $32.06 million.
&bull; Groupon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) is likely to report quarterly earnings at $0.11 per share on revenue of $136.70 million.
&bull; Townsquare Media (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSQ#NYSE">TSQ</a>) is projected to report quarterly earnings at $0.27 per share on revenue of $111.85 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Consumer Pf Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPSS#NASDAQ">CPSS</a>) is estimated to report earnings for its fourth quarter.
&bull; Legacy Housing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEGH#NASDAQ">LEGH</a>) is projected to report quarterly earnings at $0.71 per share on revenue of $60.65 million.
&bull; High Tide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $94.67 million.
&bull; Lument Finance Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LFT#NYSE">LFT</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $32.65 million.
&bull; Biofrontera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRI#NASDAQ">BFRI</a>) is likely to report quarterly loss at $1.19 per share on revenue of $11.52 million.
&bull; AlTi Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) is projected to report quarterly earnings at $0.04 per share on revenue of $66.80 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

BFRI

CBAT

CPSS

GRPN

HIBB

HITI

KVHI

LEGH

OXSQ

PALT

PRPH

SHCO

SMLP

Earnings Scheduled For March 15, 2024

AlTi Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) is set to give its latest quarterly earnings report on Friday, 2024-03-15. Here's what investors need to know before the announcement.
Analysts estimate that AlTi Global will report an earnings per share (EPS) of $0.04. 
AlTi Global bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.18, which was followed by a 7.69% drop in the share price the next day.
Here's a look at AlTi Global's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.05</td>
<td>0.09</td>
<td>0.11</td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.13</td>
<td>0.01</td>
<td>-1.19</td>
<td>-0.21</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-8.0%</td>
<td>-8.0%</td>
<td>-12.0%</td>
<td>-20.0%</td>
</tr>
</tbody>
</table>

<h3>Stock Performance</h3>
Shares of AlTi Global were trading at $6.09 as of March 13. Over the last 52-week period, shares are down 52.57%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/ALTI/earnings">To track all earnings releases for AlTi Global visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AlTi Global's Earnings: A Preview

Press Releases

AlTi Global, Inc. to Announce Second Quarter 2024 Financial Results

AlTi Tiedemann Global announces closing of previously announced strategic investment from Allianz X

AlTi Global, Inc. Reports Second Quarter 2024 Financial Results

AlTi Global, Inc. to Participate in Barclays Global Financial Services Conference

AlTi Global, Inc. to Announce Third Quarter 2024 Financial Results

AlTi Global, Inc. to Participate in JMP Securities Financial Services Conference

AlTi Global, Inc. to Participate in Wolfe Wealth Symposium

Allianz X and AlTi Tiedemann Global forge unique joint venture to pioneer UHNW wealth access to private markets alongside Allianz's balance sheet investments powered by Allianz Global Investors

Comments

AlTi Global

AlTi Global (ALTI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga